A comprehensive view of neurological / cognitive health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Teva announces Phase 1 trial to test tv-44749, an extended-release injectable suspension for schizophrenia treatment in Chinese patients; Teva yet to begin participant recruitment

Abbott and Fujirebio partner to develop neurology biomarker assay for research use on Abbott's Alinity i, aiming to enhance neuroscience research and reinforce fight against neurodegenerative diseases; availability slated for 2025

Sanofi SA raises awareness for meningitis while promoting inclusivity in lead-up to Paris 2024 Paralympics

Aptar Digital Health teams with Biogen to develop and operate digital health solutions for neurological and rare diseases; Aptar to provide product management, design, software development/maintenance, secured cloud hosting, customer and marketing support

Mount Sinai researchers discover how immune cells affect behavior during stress, potentially opening door for new depression treatments

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count